Chemo-Free Regimen Feasible in High-Risk Luminal Breast Cancer
Downstaging just as frequent with endocrine therapy plus CDK4/6 inhibitor
Related Articles
Does a Measles Infection Protect Against Cancer and Heart Disease?
HHS Secretary Robert F. Kennedy Jr. has claimed it does, but science says otherwise
NEJM Gets Letter From DOJ
It’s the fourth journal to confirm receiving a letter asking about alleged bias
Jonas Rudbaek on Predictive Neonatal Blood Biomarkers of Pediatric IBD
Inflammatory bowel disease (IBD) may be preceded by a long preclinical phase characterized by several immunologic changes, as observed for other immune-mediated inflammatory diseases. Changes…
HPV May Be Linked to Thyroid Eye Disease, Small Study Suggests
Immunological link could open up new pathways for treatment, researchers say
Antibiotic Candidate for Lyme Disease Boosts Hope for Custom Approach
Researchers also put forth one explanation for chronic symptoms after treatment
NEJM Gets Letter From DOJ
It’s the fourth journal to confirm receiving a letter asking about alleged bias
Antiviral Reduced Transmission of Influenza to Close Contacts
Baloxavir may have potential use in an influenza pandemic before a vaccine is developed
Healthcare Costs for Locally Advanced/Metastatic Urothelial Cancer
In the U.S., the economic burden associated with the latest first-line treatments for locally advanced or metastatic urothelial carcinoma (la/mUC) is significant. Drug acquisition and…
Opinion | Could Trump’s War on Harvard Spell the End of U.S. Leadership in Science?
The stop-work orders I received were far more than just a personal loss